156 related articles for article (PubMed ID: 33553341)
41. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
Schneiderman BA; Kliethermes SA; Nystrom LM
Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
[TBL] [Abstract][Full Text] [Related]
42. Risk Factors for Metastasis at Initial Diagnosis With Ewing Sarcoma.
Ye C; Dai M; Zhang B
Front Oncol; 2019; 9():1043. PubMed ID: 31681581
[No Abstract] [Full Text] [Related]
43. Bone metastasis in extremity soft tissue sarcomas: risk factors and survival analysis using the SEER registry.
Younis MH; Summers S; Pretell-Mazzini J
Musculoskelet Surg; 2022 Mar; 106(1):59-68. PubMed ID: 32638225
[TBL] [Abstract][Full Text] [Related]
44. Comparison of clinical features and outcomes in patients with extraskeletal vs skeletal Ewing sarcoma: an SEER database analysis of 3,178 cases.
Jiang S; Wang G; Chen J; Dong Y
Cancer Manag Res; 2018; 10():6227-6236. PubMed ID: 30538569
[TBL] [Abstract][Full Text] [Related]
45. Lymphatic dissemination of bone and soft tissue sarcomas: a lymphographic investigation.
Tallroth K
Acta Radiol Suppl; 1976; 349():1-84. PubMed ID: 206099
[TBL] [Abstract][Full Text] [Related]
46. Vulvar sarcoma outcomes by histologic subtype: a Surveillance, Epidemiology, and End Results (SEER) database review.
Johnson S; Renz M; Wheeler L; Diver E; Dorigo O; Litkouhi B; Behbakht K; Howitt B; Karam A
Int J Gynecol Cancer; 2020 Aug; 30(8):1118-1123. PubMed ID: 32641392
[TBL] [Abstract][Full Text] [Related]
47. Epithelial-mesenchymal transition biomarkers and support vector machine guided model in preoperatively predicting regional lymph node metastasis for rectal cancer.
Fan XJ; Wan XB; Huang Y; Cai HM; Fu XH; Yang ZL; Chen DK; Song SX; Wu PH; Liu Q; Wang L; Wang JP
Br J Cancer; 2012 May; 106(11):1735-41. PubMed ID: 22538975
[TBL] [Abstract][Full Text] [Related]
48. Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma.
Lin DZ; Qu N; Shi RL; Lu ZW; Ji QH; Wu WL
Onco Targets Ther; 2016; 9():5307-16. PubMed ID: 27601922
[TBL] [Abstract][Full Text] [Related]
49. Prognostic factors in patients with gastric adenocarcinoma using competing-risk analysis: a study of cases in the SEER database.
Zhang X; Yang J; Huang Q; Lyu J
Scand J Gastroenterol; 2019 Aug; 54(8):1015-1021. PubMed ID: 31382800
[No Abstract] [Full Text] [Related]
50. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
[TBL] [Abstract][Full Text] [Related]
51. A Competing Risk-based Prognostic Model to Predict Cancer-specific Death of Patients with Spinal and Pelvic Chondrosarcoma.
Dong Y; Xie L; Kang H; Peng R; Guo Q; Song K; Wang J; Guan H; Fang Z; Li F
Spine (Phila Pa 1976); 2021 Nov; 46(22):E1192-E1201. PubMed ID: 34714793
[TBL] [Abstract][Full Text] [Related]
52. Comparable rates of lymph node metastasis and survival between diffuse type and intestinal type early gastric cancer patients: a large population-based study.
Li ZY; Zhang QW; Teng LM; Zhang CH; Huang Y
Gastrointest Endosc; 2019 Jul; 90(1):84-95.e10. PubMed ID: 30885598
[TBL] [Abstract][Full Text] [Related]
53. Identifying the Risk Factors and Estimating the Prognosis in Patients with Pelvis and Spine Ewing Sarcoma: A Population-Based Study.
Jiang R; He S; Sun H; Gong H; Yang X; Cai X; Wei H; Xiao J
Spine (Phila Pa 1976); 2021 Oct; 46(19):1315-1325. PubMed ID: 34517400
[TBL] [Abstract][Full Text] [Related]
54. Comparing mortality of vaginal sarcoma, squamous cell carcinoma, and adenocarcinoma in the surveillance, epidemiology, and end results database.
Ghezelayagh T; Rauh-Hain JA; Growdon WB
Obstet Gynecol; 2015 Jun; 125(6):1353-1361. PubMed ID: 26000506
[TBL] [Abstract][Full Text] [Related]
55. [The role of retropharyngeal lymph node metastasis in staging of nasopharyngeal carcinoma].
Tang LL; Liu LZ; Ma J; Zong JF; Huang Y; Lin AH; Lu TX; Cui NJ
Ai Zheng; 2006 Feb; 25(2):129-35. PubMed ID: 16480573
[TBL] [Abstract][Full Text] [Related]
56. Competitive Risk Analysis of Prognosis in Patients With Cecum Cancer: A Population-Based Study.
Wu W; Yang J; Li D; Huang Q; Zhao F; Feng X; Yan H; Lyu J
Cancer Control; 2021; 28():1073274821989316. PubMed ID: 33491489
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
58. The number and ratio of positive lymph nodes are independent prognostic factors for patients with major salivary gland cancer: Results from the surveillance, epidemiology, and End Results dataset.
Qian K; Sun W; Guo K; Zheng X; Sun T; Chen L; Xiang J; Li D; Wu Y; Ji Q; Wang Z
Eur J Surg Oncol; 2019 Jun; 45(6):1025-1032. PubMed ID: 30472214
[TBL] [Abstract][Full Text] [Related]
59. Patterns and Prognostic Value of Lymph Node Metastasis on Distant Metastasis and Survival in Nasopharyngeal Carcinoma: A Surveillance, Epidemiology, and End Results Study, 2006-2015.
Xu Y; Huang T; Fan L; Jin W; Chen X; Chen J
J Oncol; 2019; 2019():4094395. PubMed ID: 31871457
[TBL] [Abstract][Full Text] [Related]
60. Improved survival after retrieval of 12 or more regional lymph nodes in appendiceal cancer.
Fleischmann I; Warschkow R; Beutner U; Marti L; Schmied BM; Steffen T
Eur J Surg Oncol; 2017 Oct; 43(10):1876-1885. PubMed ID: 28734542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
